Thomas W. Beetham Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

VRDN Quotes by TradingView

Thomas W. Beetham is Chief Operating Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 6,000 shares of VRDN, which is worth approximately $118,740. The most recent transaction as insider was on Sep 27, 2024, when has been sold 5,000 shares (Common Stock) at a price of $23.41 per share, resulting in proceeds of $117,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
n/a 3M change
n/a 12M change
Total Value Held $118,740

Thomas W. Beetham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 27 2024
BUY
Open market or private purchase
$117,050 $23.41 p/Share
5,000 Added 45.45%
6,000 Common Stock

Also insider at

KNSA
Kiniksa Pharmaceuticals, Ltd. Healthcare
EVP & Chief Legal Officer
MGTA
Magenta Therapeutics, Inc. Healthcare
Officer
TWB

Thomas W. Beetham

Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on VRDN

Follow Viridian Therapeutics, Inc.\DE and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

News

Receive news related to Viridian Therapeutics, Inc.\DE

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VRDN